Table 2.
Antimicrobial resistance pattern of bacterial isolates from ear discharge samples of study participants at Gondar University Hospital, Northwest Ethiopia (2009-2012)
| Bacterial isolates | Total NO |
Resistance pattern of antimicrobial agents (R %) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMX | CRO | CAF | CIP | ERY | CN | NOR | PG | SXT | TTC | ||
|
S. aureus |
54 |
26 (48.1) |
34 (63.0) |
13 (24.1) |
14 (25.9) |
10 (18.2) |
17 (31.5) |
16 (29.6) |
16 (29.6) |
27 (50.0) |
22 (40.7) |
25 (46.3) |
| NLF GNR |
15 |
9 (60.0) |
10 (66.7) |
4 (26.7) |
11 (73.3) |
4 (26.7) |
6 (40.0) |
5 (33.3) |
2 (13.3) |
6 (40.0) |
9 (60.0) |
10 (66.7) |
|
E.coli |
14 |
10 (71.4) |
10 (71.4) |
12 (50.0) |
1 (7.1) |
2 (14.3) |
6 (42.9) |
2 (14.3) |
1 (7.1) |
4 (28.6) |
9 (64.3) |
8 (57.1) |
|
Pseud. spps |
18 |
14 (77.8) |
13 (72.2) |
6 (33.3) |
14 (77.8) |
3 (16.7) |
5 (27.8) |
6 (33.3) |
3 (16.7) |
6 (33.3) |
12 (66.7) |
14 (77.8) |
| CN staph spps |
23 |
9 (39.1) |
3 (13.0) |
5 (21.7) |
7 (30.4) |
5 (21.7) |
5 (21.7) |
5 (21.7) |
6 (26.1) |
6 (26.1) |
11 (47.8) |
11 (47.8) |
|
Strep.spps |
12 |
6 (50.0) |
4 (33.3) |
1 (8.3) |
2 (16.7) |
3 (25.0) |
3 (25.0) |
4 (33.3) |
4 (33.3) |
5 (41.7) |
6 (50.0) |
9 (75.0) |
|
Prot. spps |
56 |
31 (55.4) |
24 (42.9) |
17 (30.4) |
32 (57.1) |
10 (17.9) |
13 (23.2) |
12 (21.4) |
12 (21.4) |
19 (33.9) |
23 (41.1) |
44 (78.6) |
| Kleb. spps | 12 | 10 (83.3) | 8 (66.7) | 7 (58.3) | 5 (41.7) | 4 (33.3) | 4 (33.3) | 4 (33.3) | 3 (25.0) | 7 (58.3) | 6 (50.0) | 5 (41.7) |
AMP Ampicillin, AMX Amoxacillin, CRO Ceftriaxone, CAF Chloramphenicol, CIP Ciprofloxacin, ERY Erythromycin, CN Gentamycin, NOR Norfluxaciline, PG Penicillin G, SXT Co-trimoxazole, TTC Tetracycline.